News & Insights
Introduction In April 2023 the EU published draft legislation which, if enacted, would represent a major shift in the regulatory and IP framework for pharmaceutical products in Europe[1] As… read more…
Mathys & Squire attorneys: David Hobson, Martin MacLean and Nicholas Fox have filed a Petition for Review on behalf of Ipsen Bioinnovation asking the European Patent Office’s (EPO)… read more…
Mathys & Squire is pleased to be ranked as a leading European patent law firm by the Financial Times (FT) in their 2024 report Mathys & Squire has also been highlighted in five… read more…
Mathys & Squire is thrilled to be ranked in the 2024 edition of IAM Patent 1000: The World’s Leading Patent Professionals IAM is known for being the definitive resource outlining… read more…
Commentary by Partner Nicholas Fox has been featured in Law Society Gazette, Law Society of Ireland Gazette, World IP Review, Life Sciences Intellectual Property Review, The Canadian Lawyer and The… read more…
Managing IP has released its 2024 guide of the IP STARS legal directory, which recognises the most outstanding practitioners covering several IP practice areas and more than 50 jurisdictions Each… read more…
In recent EPO decision T 293/19 a Technical Board of Appeal has suggested that claims to products that could be envisaged as obvious improvements over the prior art, but which could not be produced… read more…
Leading intellectual property (IP) law firm Mathys & Squire is pleased to announce the promotion of Laura Clews, Samantha Moodie and Edd Cavanna to Partners at the firm An extended version of… read more…
Commentary by Partner Andrew White has been featured in The Independent and The Patent Lawyer, discussing how R&D in defence, alongside agriculture and logistics, is driving innovation in drone… read more…